Insider Trading & Ownership - Lubner David Charles

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lubner David Charles
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2023-12-27
Sale		 2023-12-27
5:37 pm		 POINT Biopharma Global Inc. PNT Lubner David Charles
Director		 3,600 $0 $0 0
(Direct)		 View
2022-11-23
Purchase		 2022-11-28
4:03 pm		 POINT Biopharma Global Inc. PNT Lubner David Charles
Director		 3,600 $6.85 $24,660 3,600
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2024-06-04
Option Award		 2024-06-06
4:29 pm		 N/A
2034-06-03		 CARGO Therapeutics Inc. CRGX Lubner David Charles
Director		 23,742 $0 23,742
(Direct)		 View
2024-05-28
Option Award		 2024-06-06
4:15 pm		 N/A
2034-05-28		 Arcellx Inc. ACLX Lubner David Charles
Director		 8,011 $0 8,011
(Direct)		 View
2024-05-23
Option Award		 2024-05-28
4:10 pm		 N/A
2034-05-22		 Vor Biopharma Inc. VOR Lubner David Charles
Director		 30,000 $0 30,000
(Direct)		 View
2024-05-22
Option Award		 2024-05-24
5:10 pm		 N/A
2034-05-21		 Dyne Therapeutics Inc. DYN Lubner David Charles
Director		 25,133 $0 25,133
(Direct)		 View
2023-12-26
Equity Swap		 2023-12-27
5:37 pm		 N/A
N/A		 POINT Biopharma Global Inc. PNT Lubner David Charles
Director		 35,400 $0 0
(Direct)		 View
2023-11-09
Option Award		 2023-11-13
6:49 pm		 N/A
2033-11-08		 CARGO Therapeutics Inc. CRGX Lubner David Charles
Director		 25,000 $0 25,000
(Direct)		 View

Ownership		 2023-11-09
5:07 pm		 N/A
2033-08-29		 CARGO Therapeutics Inc. CRGX Lubner David Charles
Director		 0 $0 27,637
(Direct)		 View
2023-06-14
Option Award		 2023-06-16
4:17 pm		 N/A
2033-06-14		 Arcellx Inc. ACLX Lubner David Charles
Director		 11,459 $0 11,459
(Direct)		 View
2023-06-01
Option Award		 2023-06-05
5:35 pm		 N/A
2029-06-01		 POINT Biopharma Global Inc. PNT Lubner David Charles
Director		 44,749 $0 44,749
(Direct)		 View
2023-05-26
Option Award		 2023-06-02
4:36 pm		 N/A
2033-05-25		 Vor Biopharma Inc. VOR Lubner David Charles
Director		 30,000 $0 30,000
(Direct)		 View
2023-05-24
Option Award		 2023-05-25
6:37 pm		 N/A
2033-05-23		 Dyne Therapeutics Inc. DYN Lubner David Charles
Director		 24,900 $0 24,900
(Direct)		 View
2022-07-05
Option Award		 2022-07-06
6:21 pm		 N/A
2030-07-30		 Dyne Therapeutics Inc. DYN Lubner David Charles
Director		 7,222 $0 7,222
(Direct)		 View
2022-06-14
Option Award		 2022-06-16
5:05 pm		 N/A
2032-06-13		 Vor Biopharma Inc. VOR Lubner David Charles
Director		 16,911 $0 16,911
(Direct)		 View
2022-06-03
Option Award		 2022-06-06
4:07 pm		 N/A
2032-06-02		 Dyne Therapeutics Inc. DYN Lubner David Charles
Director		 19,596 $0 19,596
(Direct)		 View
2022-06-02
Option Award		 2022-06-06
4:04 pm		 N/A
2028-06-02		 POINT Biopharma Global Inc. PNT Lubner David Charles
Director		 25,614 $0 25,614
(Direct)		 View
2021-03-12
Option Award(A)		 2022-03-09
6:15 pm		 N/A
2031-03-11		 Gemini Therapeutics Inc. GMTX Lubner David Charles
Director		 17,529 $0 17,529
(Direct)		 View
2021-10-04
Option Award(A)		 2022-03-09
6:13 pm		 N/A
N/A		 Gemini Therapeutics Inc. GMTX Lubner David Charles
Director		 0 $0 0
(Direct)		 View
2022-02-08
Conversion		 2022-02-09
5:52 pm		 N/A
N/A		 Arcellx Inc. ACLX Lubner David Charles
Director		 21,659 $0 21,659
(Direct)		 View
2022-02-03
Option Award		 2022-02-07
6:00 pm		 N/A
2032-02-03		 Arcellx Inc. ACLX Lubner David Charles
Director		 61,538 $0 61,538
(Direct)		 View

Ownership		 2022-02-03
5:29 pm		 N/A
2030-08-31		 Arcellx Inc. ACLX Lubner David Charles
Director		 0 $0 132,484
(Direct)		 View
2021-10-04
Option Award		 2021-10-06
4:15 pm		 N/A
2031-10-03		 Gemini Therapeutics Inc. GMTX Lubner David Charles
Director		 17,245 $0 17,245
(Direct)		 View
2021-07-06
Option Award		 2021-07-08
4:38 pm		 N/A
2027-07-06		 POINT Biopharma Global Inc. PNT Lubner David Charles
Director		 25,000 $0 25,000
(Direct)		 View
2021-05-26
Option Award		 2021-05-27
8:37 pm		 N/A
2031-05-25		 Dyne Therapeutics Inc. DYN Lubner David Charles
Director		 19,596 $0 19,596
(Direct)		 View
2021-02-05
Option Award		 2021-04-07
4:07 pm		 N/A
2031-02-04		 Gemini Therapeutics Inc. GMTX Lubner David Charles
Director		 58,855 $0 58,855
(Direct)		 View
2021-03-12
Option Award		 2021-03-15
4:18 pm		 N/A
2031-03-11		 Gemini Therapeutics Inc. GMTX Lubner David Charles
Director		 25,000 $0 25,000
(Direct)		 View

Ownership		 2021-02-10
5:32 pm		 N/A
2030-10-15		 Gemini Therapeutics Inc. GMTX Lubner David Charles
Director		 0 $0 50,338
(Direct)		 View
2021-02-05
Option Award		 2021-02-09
5:13 pm		 N/A
2031-02-04		 Vor Biopharma Inc. VOR Lubner David Charles
Director		 16,900 $0 16,900
(Direct)		 View

Ownership		 2021-02-04
9:47 pm		 N/A
2030-08-24		 Vor Biopharma Inc. VOR Lubner David Charles
Director		 0 $0 41,196
(Direct)		 View
2020-09-21
Conversion		 2020-09-23
7:10 pm		 N/A
N/A		 Dyne Therapeutics Inc. DYN Lubner David Charles
Director		 231,497 $0 257,097
(Direct)		 View
2020-07-31
Option Award		 2020-09-23
7:10 pm		 N/A
2030-07-30		 Dyne Therapeutics Inc. DYN Lubner David Charles
Director		 25,600 $0 257,097
(Direct)		 View

Ownership		 2020-09-16
8:53 pm		 N/A
2030-03-18		 Dyne Therapeutics Inc. DYN Lubner David Charles
Director		 0 $0 112,033
(Direct)		 View

Ownership		 2020-07-07
9:51 pm		 N/A
N/A		 Therapeutics Acquisition Corp. TXAC Lubner David Charles
Director		 0 $0 30,000
(Direct)		 View
(A) Indicate amendment filing.